Yale University
New Haven, Connecticut, 06511, United States
Location status: Recruiting
NCT Number: NCT06830174
This project will apply transcranial direct current stimulation (tDCS) to multiple brain areas to evaluate the effects as a potential treatment for laryngeal dystonia (formerly spasmodic dysphonia).
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
New Haven, Connecticut, 06511, United States
Location status: Recruiting
Baseline neuroimaging data will be acquired from all participants via MRI, EEG. Each participant will be seen for multiple testing sessions over a five day period. LD participants will undergo the neuromodulation (HD-tDCS Stimulation) for twenty minutes while engaged in watching videos/movies or performing a word production task.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transcranial direct current stimulation (tDCS)
Time frame: daily on Day 1-Day 5
Cepstral peak prominence (CPP) as a robust objective measure of voice quality in the active, sham and no stimulation conditions.
Time frame: daily on Day 1-Day 5
Its primary purpose is to describe the severity of auditory-perceptual attributes of a voice problem, in a way that can be communicated among clinicians
Contact information is provided by the study sponsor or research team.
Yale University
Other
Network Targeted Transcranial Direct Current Stimulation (tDCS) as a Treatment for Laryngeal Dystonia (LD)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07443891
Dysphonia, Laryngeal Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT05095740
Central Nervous System Diseases, Dysphonia
Boston, Massachusetts, United States
View Trial DetailsNCT05150093
Dyskinesias, Dysphonia
Boston, Massachusetts, United States
View Trial DetailsNCT04421365
Dysphonia, Laryngeal Diseases
Boston, Massachusetts, United States
View Trial Details